Company Announcement - Ireland-based contract engineering design and manufacturing firm specialises in cleanroom injection moulding, assembly and other custom solutions for medical device OEMs. Molex Incorporated, a global manufacturer of complete interconnect solutions, announced today the acquisition of ProTek Medical Ltd. by Molex Ireland Holdings B.V.  Headquartered in Sligo, Ireland, ProTek Medical Ltd. specialises in supplying custom solutions for medical device manufacturers in the global medical industry.

“This strategic acquisition broadens the scope of our integrated medical solution offerings and significantly strengthens our medical device design, manufacturing, and test capabilities,” according to Tim Ruff, senior vice president of business development and corporate strategy, Molex.  “ProTek Medical Ltd. excels in cleanroom injection moulding and assembly, has an extensive metrology lab, and the quality and regulatory expertise that is critical to global medical device manufacturers.”

ProTek Medical Ltd. will continue to operate as a subsidiary of Molex Ireland Holdings, B.V.  Founded in 1995, ProTek Medical Ltd. has a diverse portfolio, with proven success in applications that include cardiac rhythm management components, infusion finished devices, and vascular delivery devices.  A recipient of numerous customer awards, ProTek Medical Ltd. has earned an industry reputation for design, engineering, manufacturing, finished assembly and testing of critical medical devices.

ProTek Medical Ltd. works closely with customers to ensure a seamless transition from prototype to production.  Their experienced team has built valued partnerships with a number of top tier medical device, biotech and pharmaceutical manufacturers in Europe and North America.  This acquisition also expands the Molex medical footprint to Ireland, which has a large concentration of successful medical device companies.

“The acquisition presents new opportunities to achieve faster growth by expanding into new regions and healthcare market segments,” added Frank Boyle, founder and CEO, ProTek Medical Ltd.  “Our customers will benefit from the unique capabilities, electromechanical technologies and global supply chain that Molex offers.   We will now have the ability to easily scale to serve high mix, low and high volume production requirements to SME and large medical device OEM customers worldwide.”